Brain slow potentials (CNV), prolactin, and schizophrenia. 1983

P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti

This is a study of possible CNV correlations to schizophrenia. Three groups of schizophrenic patients were examined: 14 patients with an initial acute psychotic illness, before and after neuroleptic therapy; 9 subjects with chronic schizophrenia, who did not require continuous neuroleptic therapy; 18 patients with chronic schizophrenia under almost continuous neuroleptic therapy for many years. The results were compared with CNV parameters of a control group. On the basis of the results obtained, the authors advance the view that the different modes of manifestation of cerebral bioelectric reactivity (CNV) are independent of treatment and are related to the different stages of the evolution of the disorder.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003265 Contingent Negative Variation A negative shift of the cortical electrical potentials that increases over time. It is associated with an anticipated response to an expected stimulus and is an electrical event indicative of a state of readiness or expectancy. Bereitschaftspotential,Readiness Potential,Bereitschaftspotentials,Contingent Negative Variations,Potential, Readiness,Potentials, Readiness,Readiness Potentials,Variation, Contingent Negative,Variations, Contingent Negative
D004594 Electrophysiology The study of the generation and behavior of electrical charges in living organisms particularly the nervous system and the effects of electricity on living organisms.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
March 1980, Acta psychologica,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
June 1988, Activitas nervosa superior,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
June 1980, Biological psychiatry,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 1978, Electroencephalography and clinical neurophysiology. Supplement,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 1979, Revue d'electroencephalographie et de neurophysiologie clinique,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 1977, Neuropsychobiology,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 1992, Zeitschrift fur experimentelle und angewandte Psychologie,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 1984, Rivista di neurologia,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
March 1977, Biological psychology,
P A Rizzo, and G F Albani, and M Spadaro, and C Morocutti
January 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Copied contents to your clipboard!